Publications by authors named "Nani Hersunarti"
Article Synopsis
- Iron deficiency anemia (IDA) in heart failure (HF) negatively impacts a patient’s ability to function, and previous studies suggest that iron therapy may help improve this capacity.
- A randomized controlled trial involving 54 participants with heart failure and IDA tested the effects of oral Ferrous Sulphate (FS) versus a placebo for 12 weeks, measuring results through a six-minute walk test.
- Results showed that patients taking Ferrous Sulphate experienced significant improvements in functional capacity compared to those receiving the placebo, indicating that oral iron supplementation effectively enhances functional ability in HF patients with IDA.
Background: Hospital length of stay (LOS) is a key determinant of heart failure hospitalization costs. Longer LOS is associated with lower quality of care measures and higher rates of readmission and mortality. Right ventricular (RV) dysfunction predicted poor outcomes in patients with stable chronic heart failure (CHF), however, its prognostic value in the acute decompensated heart failure (ADHF) patients has not been sufficiently clarified.
View Article and Find Full Text PDF